2024. Laboratory Parameters in Adolescent Patients Aged 12–17 with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab Up to Week 52: Results from the Phase 3 ECZTRA 6 Trial. SKIN The Journal of Cutaneous Medicine. 8, 1 (Jan. 2024), s323. DOI:https://doi.org/10.25251/skin.8.supp.323.